Iteos Therapeutics Inc (ITOS)

Dec 21, 2024

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Dec 21, 2024

Dec 20, 2024

iTeos Therapeutics price target lowered to $19 from $31 at Wells Fargo - Yahoo Finance

Dec 20, 2024

Dec 19, 2024

iTeos Therapeutics (NASDAQ:ITOS) Price Target Cut to $19.00 by Analysts at Wells Fargo & Company - MarketBeat

Dec 19, 2024

Dec 18, 2024

Inupadenant “deprioritised” by iTeos in favour of pipeline TIGIT therapy - MSN

Dec 18, 2024

Dec 17, 2024

Merck, iTeos dropping assets, Viridian data — BioCentury’s Clinical Report - BioCentury

Dec 17, 2024

Dec 17, 2024

iTeos Therapeutics: A Perhaps Unjustified Decline To End 2024 - Seeking Alpha

Dec 17, 2024

Dec 16, 2024

Charles Schwab Investment Management Inc. Buys 8,397 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Dec 16, 2024

Dec 16, 2024

iTeos Therapeutics’ (ITOS) Buy Rating Reiterated at HC Wainwright - Defense World

Dec 16, 2024

Dec 13, 2024

iTeos Therapeutics (NASDAQ:ITOS) Earns Buy Rating from HC Wainwright - MarketBeat

Dec 13, 2024

Dec 13, 2024

Iteos Therapeutics stock hits 52-week low at $7.52 - Investing.com India

Dec 13, 2024

Dec 13, 2024

Cancer Pipelines Shrink as Incyte, iTeos Cut Candidates Following Disappointing Data - BioSpace

Dec 13, 2024

Dec 12, 2024

Inupadenant shows promise in NSCLC Phase 2 trial results - Investing.com

Dec 12, 2024

Dec 12, 2024

iTeos Therapeutics Presents Interim A2A-005 Clinical Trial - GlobeNewswire

Dec 12, 2024

Dec 12, 2024

ITeos Therapeutics, Inc. Presents Interim A2A-005 Clinical Trial Data, Translational, and Preclinical Data from Inupadenant at ESMO Immuno-Oncology Congress - Marketscreener.com

Dec 12, 2024

Dec 08, 2024

Intech Investment Management LLC Invests $154,000 in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Dec 08, 2024

Dec 05, 2024

RA Capital Management L.P. Cuts Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat

Dec 05, 2024

Dec 04, 2024

(ITOS) Technical Data - Stock Traders Daily

Dec 04, 2024

Nov 30, 2024

Quest Partners LLC Has $113,000 Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Nov 30, 2024

Nov 29, 2024

Vestal Point Capital LP Has $10.47 Million Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat

Nov 29, 2024

Nov 28, 2024

Victory Capital Management Inc. Lowers Stock Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Nov 28, 2024

Nov 27, 2024

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares Bought by Algert Global LLC - MarketBeat

Nov 27, 2024

Nov 26, 2024

iTeos annonce sa participation aux prochaines journées Investisseurs - GlobeNewswire Inc.

Nov 26, 2024

Nov 26, 2024

iTeos to Participate in Upcoming Investor Conferences - GlobeNewswire

Nov 26, 2024

Nov 26, 2024

iTeos Therapeutics to Present at Evercore and Piper Sandler Healthcare Conferences | ITOS Stock News - StockTitan

Nov 26, 2024

Nov 24, 2024

GSA Capital Partners LLP Purchases New Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Nov 24, 2024

Nov 24, 2024

Empowered Funds LLC Increases Stock Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Nov 24, 2024

Nov 23, 2024

(ITOS) On The My Stocks Page - Stock Traders Daily

Nov 23, 2024

Nov 22, 2024

BIOTECHNOLOGY VALUE FUND L P Increases Stake in ITeos Therapeuti - GuruFocus.com

Nov 22, 2024

Nov 22, 2024

Iteos Therapeutics stock hits 52-week low at $7.58 By Investing.com - Investing.com South Africa

Nov 22, 2024

Nov 21, 2024

Insider Buying: Matthew Gall Acquires 5,000 Shares of ITeos Ther - GuruFocus.com

Nov 21, 2024

Nov 21, 2024

Iteos Therapeutics stock hits 52-week low at $7.58 - Investing.com

Nov 21, 2024

Nov 20, 2024

iTeos Therapeutics CFO Matthew Gall acquires $38,635 in common stock - Investing.com India

Nov 20, 2024

Nov 19, 2024

iTeos Therapeutics CFO Matthew Gall acquires $38,635 in common stock By Investing.com - Investing.com UK

Nov 19, 2024

Nov 16, 2024

Equities Analysts Offer Predictions for ITOS FY2024 Earnings - Defense World

Nov 16, 2024

Nov 16, 2024

US Bancorp DE Has $123,000 Stake in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Nov 16, 2024

Nov 15, 2024

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year - Simply Wall St

Nov 15, 2024

Nov 15, 2024

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance

Nov 15, 2024

Nov 15, 2024

HC Wainwright Reaffirms Buy Rating for iTeos Therapeutics (NASDAQ:ITOS) - MarketBeat

Nov 15, 2024

Nov 15, 2024

EcoR1 Capital, LLC Reduces Stake in ITeos Therapeutics Inc - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

FY2024 EPS Forecast for iTeos Therapeutics Lifted by Analyst - MarketBeat

Nov 15, 2024

Nov 14, 2024

Iteos Therapeutics stock hits 52-week low at $8.39 - Investing.com

Nov 14, 2024

Nov 14, 2024

Wedbush Reaffirms Outperform Rating for iTeos Therapeutics (NASDAQ:ITOS) - Defense World

Nov 14, 2024

Nov 13, 2024

iTeos Therapeutics Reports Q3 2024 Financial Results - TipRanks

Nov 13, 2024

Nov 12, 2024

Creative Planning Acquires 1,196 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Nov 12, 2024

Nov 12, 2024

iTeos Reports Third Quarter 2024 Financial Results and Provides Business Updates - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

iTeos Reports Wider Q3 Loss, Maintains $684M Cash Runway Through 2027 | ITOS Stock News - StockTitan

Nov 12, 2024

Oct 31, 2024

Iteos Therapeutics stock hits 52-week low at $8.49 - Investing.com India

Oct 31, 2024

Oct 30, 2024

Iteos Therapeutics stock hits 52-week low at $8.49 By Investing.com - Investing.com South Africa

Oct 30, 2024

Oct 24, 2024

iTeos Therapeutics to Highlight Inupadenant Preclinical, Translational, and Phase 2 A2A-005 Clinical Trial Data in 2L NSCLC at ESMO Immuno-Oncology Congress - GlobeNewswire

Oct 24, 2024

Oct 24, 2024

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares Purchased by nVerses Capital LLC - Defense World

Oct 24, 2024

Oct 23, 2024

Iteos Therapeutics stock hits 52-week low at $8.73 - Investing.com India

Oct 23, 2024